Evidence map›Paper›PMID 30959514›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2019

Neurophysiological signature of gamma-hydroxybutyrate augmented sleep in male healthy volunteers may reflect biomimetic sleep enhancement: a randomized controlled trial.

Dario A Dornbierer, Diego M Baur, Benjamin Stucky, Boris B Quednow, Thomas Kraemer, Erich Seifritz, Oliver G Bosch, Hans-Peter Landolt

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Gamma-hydroxybutyrate to promote slow-wave sleep in major depressive disorder: a randomized crossover trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Review
  10. Hallmarks of primary headache: part 3 - cluster headache.The journal of headache and pain · 2025
    Review
  11. Current knowledge on the pathophysiology of idiopathic hypersomnia and potential mechanisms of action for low-sodium oxybate treatment.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Sleep, Narcolepsy, and Sodium Oxybate.Current neuropharmacology · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dario A DornbiererInstitute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland. dornbierer@pharma.uzh.ch.
Diego M BaurInstitute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.
Benjamin StuckyInstitute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-7425-2927
Boris B QuednowDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Lenggstrasse 31, Zürich, CH-8032, Switzerland.ORCID http://orcid.org/0000-0001-7933-2865
Thomas KraemerDepartment of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zürich, Zürich, Switzerland.
Erich SeifritzDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Lenggstrasse 31, Zürich, CH-8032, Switzerland.
Oliver G BoschDepartment of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Lenggstrasse 31, Zürich, CH-8032, Switzerland.ORCID http://orcid.org/0000-0002-5807-0859
Hans-Peter LandoltInstitute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-0887-9403
University of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gamma-hydroxybutyrate (GHB) is an endogenous GHB/GABA

Indexed as

AdultCross-Over StudiesDouble-Blind MethodElectroencephalographyGABA-B Receptor AgonistsHealthy VolunteersHumansMaleSleepSodium OxybateYoung AdultGABA-B Receptor AgonistsSodium Oxybate

Identifiers

PMID30959514
PMCPMC6785068
OpenAlexW2938627670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.